Bioimplants Market Size was valued at USD 98.30 Billion in 2023. The Global Bioimplants industry is projected to grow from USD 100.98 Billion in 2024 to USD 273.45 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.99% during the forecast period (2024 - 2032).
Bioimplants are bioengineered items that are utilized to repair the physiological functioning of a damaged biostructure. The method involves the replacement, support, or enhancement of a missing, damaged, or existent biological structure. Rising incidences of bone deterioration in the older population, rising demand for minimally invasive operations, rising prevalence of lifestyle illnesses such as obesity, diabetes, and infections, and technological innovation in the healthcare sector are projected to fuel market expansion.
Furthermore, increased R&D activities and aggressive strategies are taken by leading competitors are pushing the growth of the bioimplants market. The growing cost of bioimplant procedures and the appropriate use of bioimplant products may stymie market expansion over the assessment period. The market is expected to grow exponentially in the upcoming years.
The Bioimplants Market has been segmented on the basis of type, material, origin and end-user.On the basis of type, the market has been classified as cardiovascular implant, dental implants, spinal bio-implants, orthopedic implants, ophthalmic implants and others. The cardiovascular implant segment has been further divided into stents, pacing devices and others. Dental implants are classified into plate form dental implant and root form dental implants. The spinal bioimplants segment has been further divided into form dental implant, intervertebral spacers, cervical implants, and motion preservation implants. Orthopedic Implants are divided into orthobiologics, trauma implants, joint replacement implants, and knee replacement implants. The ophthalmic implants segmented has been classified into glaucoma implants, and intraocular implants.
The material segment is divided into biomaterial metals, ceramics, alloys, and others. The biomaterial metals segment has been divided into titanium, gold, silver and platinum. Based on origin, the bioimplants market has been segmented into autograft, allograft, xenograft, and synthetic. The market, by end-user, has been segmented into hospitals, clinics, specialty centers, and others. The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The bioimplants market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European Bioimplants Market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.The Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Bioimplants Market Key Players
The Americas are expected to dominate the global bioimplants market owing to the rising prevalence of chronic diseases in the aging population, rising prevalence of lifestyle disorders such as obesity and diabetes, increase in the number of surgical procedures, and adoption of highly advanced technology. According to the Centers for Disease Control and Prevention, in 2016, approximately 93 million Americans were suffering from obesity and it is close to 40% of the total population. Increasing obesity is a result of changing lifestyle and rising consumption of junk food.
The European bioimplants market is expected to be the second-largest market. The market growth in this region can be attributed to government funding and support of the healthcare, rising occurrence of orthopedic disorders and increasing research and development activities in the healthcare sector. Moreover, increasing number of cardiovascular surgeries due to rise in number of cardiovascular disorders in the region is propelling the growth of the market. According to the European Heart Network, in 2015, more than 85 million patients were suffering from Cardiovascular diseases in Europe and it caused more than 1.8 million deaths in European union.
Asia-Pacific is expected to be the fastest-growing bioimplants market during the forecast period owing to the increasing geriatric population, increasing disposable income, rising investments in healthcare and expansions by market players in the region, and rising cases of spinal cord injury due to increasing road accidents. According to the United Nations ESCAP, social development division, more than 12.4% of total Asian population in 2016 was above 60 years and expected to reach 1.3 billion by the end of 2050.
The market in the Middle East & Africa is expected to account for the smallest share of the global bioimplants market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Recent Development
Boston Scientific is a medical solution innovator that helps patients all around the world to better their health. Boston Scientific's products and technologies are used to diagnose and treat a variety of medical diseases, including cardiac, digestive, pulmonary, vascular, and urological, women's health, and chronic pain. Boston scientific has enhanced the practice of minimally invasive medicine by offering a diverse portfolio of new products, technologies, and services in a variety of medical disciplines. These minimally invasive medical technologies provide alternatives to major surgery and other invasive medical treatments. Less invasive methods include inserting devices into the body through natural openings or minor incisions and guiding them to most parts of the anatomy to diagnose and cure a condition.
DENTSPLY's extensive worldwide product portfolio enables dental practitioners to provide patients with oral health care for the rest of their lives, from preventative treatments to tooth replacement. Their goods span from ordinary dental consumables and laboratory items to products that serve the orthodontic, endodontic, and implant sectors.
Intended Audience
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â USD 273.45 Billion |
| Â Â CAGR | Â Â 5.99% |
| Â Â Base Year | Â Â 2021 |
| Â Â Forecast Period | Â Â 2024-2032 |
| Â Â Historical Data | Â Â 2020 |
| Â Â Forecast Units | Â Â Value (USD Million) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â By Type, Material, Origin, End-User |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Â Â Abbott Boston Scientific Corporation, Dentsply Sirona, Johnson & Johnson Services, Inc., Invibio Ltd, Integra LifeSciences, Medtronic, Smith & Nephew plc, Stryker, Wright Medical Group N.V., Zimmer Biomet, Cook Group, R. Bard, Inc. |
| Â Â Key Market Opportunities | Â Â Joint ventures, strategic alliances, mergers and acquisitions and new product developments |
|   Key Market Drivers | · Rising cases of bone degeneration cases · Increasing demand for minimally invasive surgeries |
Bioimplants Market Highlights:
Bioimplants Market is expected to grow USD 262.42 billion at a CAGR 5.40% during the forecast period 2022-2030
$262.42 Billion
5.40%
North America
2022-2030
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
